Methadone

Methadone is a long-acting synthetic opioid with two main medical uses: treating opioid use disorder (as a maintenance medication that prevents withdrawal and reduces craving) and managing severe pain. As a treatment for opioid addiction it is well-established and life-saving — it lets people stabilize without the cycle of withdrawal and is delivered through regulated programs. At the same time it is a full opioid, so it carries the class risks of respiratory depression and dependence, and it has a particular hazard: because it is long-acting and accumulates in the body, its dangers are easy to underestimate, and overdose risk is highest early in treatment before the right dose is established. It is both one of the most useful tools against the opioid crisis and a drug that demands careful medical supervision.

Methadone is a mu-opioid receptor agonist like other opioids, producing pain relief and preventing opioid withdrawal, but it differs in two important ways: it acts slowly and lasts a long time in the body. This long duration is exactly what makes it useful for treating addiction — it provides steady opioid-receptor activity that suppresses withdrawal and craving without the rapid peaks and troughs of shorter-acting opioids. But the same property makes it dangerous if dosed carelessly: methadone can build up over repeated doses, and its effects (including breathing suppression) can outlast what a person feels, so the risk of overdose is greatest while a dose is being established. It also can affect heart rhythm (QT prolongation) in some people. Tolerance and physical dependence develop with use.

Used as prescribed, methadone prevents opioid withdrawal and craving without producing a strong high, which is what allows people in treatment to function normally. Common effects include drowsiness, constipation, sweating, dry mouth, and nausea, especially when starting. Because it is long-acting, sedation and breathing suppression can come on gradually and persist. At higher-than-tolerated doses the opioid dangers dominate: heavy sedation, confusion, and slow, shallow breathing. Stopping after regular use produces opioid withdrawal, which with methadone tends to be slower in onset and more prolonged than with shorter-acting opioids. In treatment settings, the goal is a steady dose that produces neither withdrawal nor intoxication.

Methadone's central danger is respiratory depression, and its long-acting, accumulating nature makes the timing of risk distinctive: overdose risk is highest in the first days to weeks of use, before a stable dose is reached, because the drug builds up and its breathing-suppressing effect can outlast the felt effect. The risk rises sharply when methadone is combined with other depressants — alcohol, benzodiazepines, or other opioids — which is a frequent factor in methadone deaths. Methadone can also affect heart rhythm in some people. None of this is a reason to avoid methadone treatment, which is proven to save lives; it is a reason it must be taken exactly as prescribed and not combined with other depressants. Naloxone (Narcan) reverses a methadone overdose but, because methadone is long-acting, repeat doses and monitoring are often needed; it is over the counter in the U.S. since 2023 and safe to give regardless — give it and call 911 for slow or stopped breathing or unresponsiveness. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.